We support reforms which will allow all Canadians to access the medicines they need when needed, equitably and consistently, as outlined in our core positions and principles, and in formal submissions.
National Strategy for High-Cost Drugs for Rare Diseases:
BMC’s Submission to the National Strategy for High-Cost Drugs for Rare Diseases Online Engagement (March 26, 2021)
Pharmacare Advisory Council:
BMC’s Position Points on Key Recommendations
Joint Discussion Paper:
Better Pharmacare For Patients: Evaluating Policy Options (Français)